Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Other Long-Term Liabilities : ¥317 Mil (As of Mar. 2025)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Other Long-Term Liabilities?

Jiangsu Hengrui Pharmaceuticals Co's other long-term liabilities for the quarter that ended in Mar. 2025 was ¥317 Mil.

Jiangsu Hengrui Pharmaceuticals Co's quarterly other long-term liabilities increased from Sep. 2024 (¥126 Mil) to Dec. 2024 (¥343 Mil) but then declined from Dec. 2024 (¥343 Mil) to Mar. 2025 (¥317 Mil).

Jiangsu Hengrui Pharmaceuticals Co's annual other long-term liabilities declined from Dec. 2022 (¥220 Mil) to Dec. 2023 (¥123 Mil) but then increased from Dec. 2023 (¥123 Mil) to Dec. 2024 (¥343 Mil).

Jiangsu Hengrui Pharmaceuticals Co Other Long-Term Liabilities Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Other Long-Term Liabilities Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long-Term Liabilities

Get a 7-Day Free Trial

171.00

141.29

219.89

122.59

342.76

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Long-Term Liabilities	Get a 7-Day Free Trial															124.18	127.64	125.71	342.76	317.42

Jiangsu Hengrui Pharmaceuticals Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Jiangsu Hengrui Pharmaceuticals Co Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Jiangsu Hengrui Pharmaceuticals Co's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Jiangsu Hengrui Pharmaceuticals Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

01276:Hong Kong

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Executives

Zhang Lian Shan	Directors, senior managers
Sun Xu Gen	senior management
Yuan Kai Hong	senior management
Zou Jian Jun	senior management
	senior management
Zhang Yue Hong	senior management
Liu Xiao Han	senior management
Zhou Yun Shu	Directors, senior managers
Liao Cheng	senior management
Wang Hong Sen	senior management
Zhou Song	senior management
Tao Wei Kang	senior management
Jiang Su Mei	senior management
Dai Hong Bin	Directors, senior managers
Sun Jie Ping	Directors, senior managers

Jiangsu Hengrui Pharmaceuticals Co Headlines

No Headlines